Form 4 for BLTE BELITE BIO, INC
Accepted 2026-05-01 16:15:05 ET · period of report 2026-04-30 · accession 0001193125-26-201466 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MT | 2026-05-01 16:15 | 2026-04-30 | BLTE | MATA NATHAN L. | CSO | S - Sale | $156.97 | -1,000 | 4,666 | -18% | -$157.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | American depositary share | 2026-04-30 | S | D | 42 | $155.68 | 5,624 | D | — | — | (F1) Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. (F3) Represents the weighted average price of shares sold at prices that ranged from $155.62 to $155.87. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
| 2 | Common | American depositary share | 2026-04-30 | S | D | 517 | $156.59 | 5,107 | D | — | — | (F1) Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. (F4) Represents the weighted average price of shares sold at prices that ranged from $156.095 to $156.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
| 3 | Common | American depositary share | 2026-04-30 | S | D | 340 | $157.37 | 4,767 | D | — | — | (F1) Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. (F5) Represents the weighted average price of shares sold at prices that ranged from $157 to $157.99. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |
| 4 | Common | American depositary share | 2026-04-30 | S | D | 101 | $158.15 | 4,666 | D | — | — | (F1) Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the issuer. (F2) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/10/2025. (F6) Represents the weighted average price of shares sold at prices that ranged from $158.01 to $158.42. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. |